I am pleased to announce that our GMP facility has been expanded with the lease of additional manufacturing space for DIAB
all patent rights for use of DIAB
II that arise from this new patent .
We are very pleased that DIAB
II has received full approval for sale in Peru as a prescription treatment for Type II Diabetes.
This is an important step in bringing DIAB
II to one of the largest and fastest-growing pharmaceutical markets in the world.
In Mexico, we expect to file a DIAB
II registration dossier in the next 30 days and project an approval in the first half of 2002.
In exchange for Immunis' interest in DIAB
II, Biotech Holdings has agreed to issue, to Immunis Corp.
Rieveley said that additional safety information is being provided about DIAB
II, which is not a glitazone.
Bilim's very extensive manufacturing experience may also prove important for expediting the supply of DIAB
II to the Turkish market and to some of the export markets into which Bilim regularly sells pharmaceutical products," Mr.
In Brazil, our Registration Dossier for DIAB
II has been in the hands of our licensee since March.
We believe that the extensive regulatory experience that Micrometrix brings to our partnership will be invaluable for guiding our DIAB
II regulatory application and that our partner's manufacturing capabilities will enhance our prospects for a timely launch of DIAB
II in Mexico," Rieveley said.
to submit their application to have DIAB
II approved for sale in the Brazilian market, a leading drug market in Latin America.
s (OTC Bulletin Board: IMMC) President, Colin Leech-Porter, announced today that the specialized controlled-environmental area for the production of DIAB
II at Biotech Holdings Ltd.